Biomarkers of the Endocannabinoid System in Substance Use Disorders

Despite substance use disorders (SUD) being one of the leading causes of disability and mortality globally, available therapeutic approaches remain ineffective. The difficulty in accurately characterizing the neurobiological mechanisms involved with a purely qualitative diagnosis is an obstacle to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarrete, Francisco, García-Gutiérrez, María S., Gasparyan, Ani, Navarro, Daniela, López-Picón, Francisco, Morcuende, Álvaro, Femenía, Teresa, Manzanares, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946268/
https://www.ncbi.nlm.nih.gov/pubmed/35327588
http://dx.doi.org/10.3390/biom12030396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946268/
https://www.ncbi.nlm.nih.gov/pubmed/35327588
http://dx.doi.org/10.3390/biom12030396

Ejemplares similares